Selected Grants
Manipulating normal estrogen physiology as a therapeutic approach in cancer
ResearchAssociate Research Professor · Awarded by National Cancer Institute · 2023 - 2028Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
ResearchAssociate Research Professor · Awarded by National Institutes of Health · 2022 - 2027HOXB13 as a therapeutic target in prostate cancer
ResearchAssociate Research Professor · Awarded by Prostate Cancer Foundation · 2020 - 2024Cancer cell intrinsic and extrinsic actions of steroid hormones in breast tumors
ResearchAssociate Research Professor · Awarded by Department of Defense · 2018 - 2023Role of ER RNA Binding Domain in Breast Cancer
ResearchAssistant Research Professor · Awarded by Ribometrix LLC · 2022 - 2022Identification of Novel Targets in Treatment Resistant Prostate Cancer
ResearchAssociate Research Professor · Awarded by Celgene Corporation · 2017 - 2022Androgen Receptor Cofactor Profiling of Nido AR Ligands
ResearchPrincipal Investigator · Awarded by Nido Biosciences, Inc. · 2021 - 2022Development of mechanistically distinct androgen receptor antagonists and degraders for the treatment of advanced castration resistant prostate cancer
ResearchAssociate Research Professor · Awarded by Department of Defense · 2015 - 2019Evaluation of G1 antiestrogens in models of estrogen action
ResearchAssociate Research Professor · Awarded by G1 Therapeutics Inc. · 2018 - 2019Evaluation of G1T48 in models of estrogen action
ResearchAssociate Research Professor · Awarded by G1 Therapeutics Inc. · 2017 - 2018Optimization of ERalpa-LBD-based CAR-T switch
ResearchAssociate Research Professor · Awarded by Cell Design Labs, Inc · 2017 - 2018Evaluation of the SERD XR5-28 in models of estrogen action
ResearchAssociate Research Professor · Awarded by G1 Therapeutics Inc. · 2016 - 2017Evaluation of the therapeutic potential of combining VT464 and G1T38 in treatment-resistant prostate and breast cancer models
ResearchAssociate Research Professor · Awarded by Innocrin Pharmaceutical, Inc. · 2016 - 2017Targeting the CDK 4/6 axis in Castration Resistant Prostate Cancer
ResearchAssociate Research Professor · Awarded by G1 Therapeutics Inc. · 2015 - 2016Evaluation of VT-464 in AR positive and ER positive breast cancer models
ResearchAssociate Research Professor · Awarded by Innocrin Pharmaceutical, Inc. · 2015 - 2016Determination of the antiandrogenic properties of VT-464, a novel CYP17 lyase inhibitor
ResearchAssociate Research Professor · Awarded by Viamet Pharmaceuticals · 2014 - 2015Molecular Determinants of Androgen Receptor Pharmacology
ResearchAssociate Research Professor · Awarded by National Institutes of Health · 2003 - 2013Integrated instrument systems for maintenance and delivery of RNAi libraries
EquipmentCo Investigator · Awarded by National Institutes of Health · 2008 - 2009External Relationships
- BMS Corporation
- Nido
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.